{"id":4690,"date":"2019-01-09T12:06:47","date_gmt":"2019-01-09T14:06:47","guid":{"rendered":"http:\/\/srv.portalnpm.com.br\/?p=4690"},"modified":"2019-01-09T12:06:47","modified_gmt":"2019-01-09T14:06:47","slug":"sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina","status":"publish","type":"post","link":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/","title":{"rendered":"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina"},"content":{"rendered":"<p style=\"text-align: justify;\">O Minist\u00e9rio da Sa\u00fade informou ter ampliado o tratamento oferecido a pacientes com degenera\u00e7\u00e3o macular relacionada \u00e0 idade por meio da oferta do medicamento antigiog\u00eanico e do exame de tomografia de coer\u00eancia \u00f3ptica. Segundo a pasta, ambas as incorpora\u00e7\u00f5es s\u00e3o importantes para a detec\u00e7\u00e3o precoce e para tratar casos j\u00e1 confirmados, estabilizando a evolu\u00e7\u00e3o da doen\u00e7a. A degenera\u00e7\u00e3o macular atinge a parte central da retina e leva \u00e0 perda progressiva da vis\u00e3o central.<\/p>\n<p style=\"text-align: justify;\">Os dois novos procedimentos devem atender pacientes a partir dos 60 anos, conforme Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Degenera\u00e7\u00e3o Macular Relacionada \u00e0 Idade. O medicamento antigiog\u00eanico \u00e9 injet\u00e1vel e pode ser feito em um ou nos dois olhos, com intervalo m\u00ednimo de 15 dias entre um olho e outro. J\u00e1 a tomografia de coer\u00eancia \u00f3ptica \u00e9 um exame n\u00e3o invasivo para diagn\u00f3stico da doen\u00e7a nos dois olhos. A proposta \u00e9 detectar sinais microsc\u00f3picos de altera\u00e7\u00f5es precoces da retina.<\/p>\n<p style=\"text-align: justify;\"><strong>A doen\u00e7a<\/strong><\/p>\n<p style=\"text-align: justify;\">A degenera\u00e7\u00e3o macular relacionada \u00e0 idade \u00e9 uma doen\u00e7a progressiva que acomete a \u00e1rea central da retina, onde as imagens s\u00e3o formadas, levando invariavelmente \u00e0 perda da vis\u00e3o central. O principal fator de risco \u00e9 o aumento da idade. A doen\u00e7a pode ser classificada como seca, respons\u00e1vel pela maior parte dos casos (85%-90%), ou \u00famida (10%-15%).<\/p>\n<p style=\"text-align: justify;\"><strong>Fonte:<\/strong> Ag\u00eancia Brasil<\/p>\n","protected":false},"excerpt":{"rendered":"<p>O Minist\u00e9rio da Sa\u00fade informou ter ampliado o tratamento oferecido a pacientes com degenera\u00e7\u00e3o macular relacionada \u00e0 idade por meio da oferta do medicamento antigiog\u00eanico e do exame de tomografia de coer\u00eancia \u00f3ptica. Segundo a pasta, ambas as incorpora\u00e7\u00f5es s\u00e3o importantes para a detec\u00e7\u00e3o precoce e para tratar casos j\u00e1 confirmados, estabilizando a evolu\u00e7\u00e3o da &hellip;<\/p>\n","protected":false},"author":8,"featured_media":4691,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"facebook_2648258775420054_1618374048415101":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":"","_jetpack_memberships_contains_paid_content":false},"categories":[113,384],"tags":[1105,1769,1893,781],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina - Portal NPM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina - Portal NPM\" \/>\n<meta property=\"og:description\" content=\"O Minist\u00e9rio da Sa\u00fade informou ter ampliado o tratamento oferecido a pacientes com degenera\u00e7\u00e3o macular relacionada \u00e0 idade por meio da oferta do medicamento antigiog\u00eanico e do exame de tomografia de coer\u00eancia \u00f3ptica. Segundo a pasta, ambas as incorpora\u00e7\u00f5es s\u00e3o importantes para a detec\u00e7\u00e3o precoce e para tratar casos j\u00e1 confirmados, estabilizando a evolu\u00e7\u00e3o da &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/\" \/>\n<meta property=\"og:site_name\" content=\"Portal NPM\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-09T14:06:47+00:00\" \/>\n<meta name=\"author\" content=\"Zenilton Lima\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Zenilton Lima\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/\",\"url\":\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/\",\"name\":\"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina - Portal NPM\",\"isPartOf\":{\"@id\":\"https:\/\/portalnpm.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2019-01-09T14:06:47+00:00\",\"dateModified\":\"2019-01-09T14:06:47+00:00\",\"author\":{\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e\"},\"breadcrumb\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/portalnpm.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/portalnpm.com\/#website\",\"url\":\"https:\/\/portalnpm.com\/\",\"name\":\"Portal NPM\",\"description\":\"Not\u00edcias em Primeira M\u00e3o\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/portalnpm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e\",\"name\":\"Zenilton Lima\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg\",\"contentUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg\",\"caption\":\"Zenilton Lima\"},\"url\":\"https:\/\/portalnpm.com\/index.php\/author\/zenilton\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina - Portal NPM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/","og_locale":"pt_BR","og_type":"article","og_title":"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina - Portal NPM","og_description":"O Minist\u00e9rio da Sa\u00fade informou ter ampliado o tratamento oferecido a pacientes com degenera\u00e7\u00e3o macular relacionada \u00e0 idade por meio da oferta do medicamento antigiog\u00eanico e do exame de tomografia de coer\u00eancia \u00f3ptica. Segundo a pasta, ambas as incorpora\u00e7\u00f5es s\u00e3o importantes para a detec\u00e7\u00e3o precoce e para tratar casos j\u00e1 confirmados, estabilizando a evolu\u00e7\u00e3o da &hellip;","og_url":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/","og_site_name":"Portal NPM","article_published_time":"2019-01-09T14:06:47+00:00","author":"Zenilton Lima","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Zenilton Lima","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/","url":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/","name":"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina - Portal NPM","isPartOf":{"@id":"https:\/\/portalnpm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#primaryimage"},"image":{"@id":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#primaryimage"},"thumbnailUrl":"","datePublished":"2019-01-09T14:06:47+00:00","dateModified":"2019-01-09T14:06:47+00:00","author":{"@id":"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e"},"breadcrumb":{"@id":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/portalnpm.com\/index.php\/2019\/01\/09\/sus-oferece-novo-tratamento-para-pacientes-com-degeneracao-da-retina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/portalnpm.com\/"},{"@type":"ListItem","position":2,"name":"SUS oferece novo tratamento para pacientes com degenera\u00e7\u00e3o da retina"}]},{"@type":"WebSite","@id":"https:\/\/portalnpm.com\/#website","url":"https:\/\/portalnpm.com\/","name":"Portal NPM","description":"Not\u00edcias em Primeira M\u00e3o","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/portalnpm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/35cb55186eae3f074b6783da6d35591e","name":"Zenilton Lima","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/image\/","url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg","contentUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/12\/avatar_user_8_1733658137-96x96.jpeg","caption":"Zenilton Lima"},"url":"https:\/\/portalnpm.com\/index.php\/author\/zenilton\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/4690"}],"collection":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/comments?post=4690"}],"version-history":[{"count":0,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/4690\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/media?parent=4690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/categories?post=4690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/tags?post=4690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}